Full Text View
Tabular View
No Study Results Posted
Related Studies
A Continuation Trial for Subjects With Lupus Who Completed Protocol HGS1006-C1056 in the United States
This study is ongoing, but not recruiting participants.
Study NCT00724867   Information provided by GlaxoSmithKline

First Received on July 28, 2008.   Last Updated on March 22, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Systemic Lupus Erythematosus
Additional conditions recognized in this trial
Lupus Erythematosus, Systemic
More general conditions related to this trial
Autoimmune Diseases
Connective Tissue Diseases
Immune System Diseases
Interventions listed in this trial
Belimumab 1 mg/kg
Belimumab 10 mg/kg
Sponsors listed in this trial
Human Genome Sciences Inc., a GSK Company
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services